Dabur is an Indian consumer goods company that was founded in 1884 and has since transformed from a slow, unresponsive company into an aggressive and innovative one, undertaking new initiatives in exports and acquisitions. Dabur had 2005 sales of 1,269 crores with 1,870 employees and major operations in personal care, health care, and foods. Its leading brands include Dabur Amla, Chyawanaprash, Vatika, Hajmola, and Real fruit juices. In 2003, Dabur Pharmaceuticals became a separate entity. To further growth, Dabur planned to restructure sales and distribution with a 200 crore war chest for acquisitions, such as

1. DABUR

2. Reasons for Selecting Dabur
• Dabur is a company that has transformed
itself from a staid and unresponsive
company to a company which is
aggressive and innovative
• A lot of new initiatives in the fields of
exports and acquisitions.

3. HISTORY
• Started in 1884 by Dr. V.C. Burman
• “Daktar Burman”
• Since 1930, the company operated under
the name Dabur (S K Burman) Pvt. Ltd.
• Dabur India Limited was formed by way of
amalgamation in Oct.'86
• Dabur Pharmaceuticals a separate entity
in 2003

4. PROFILE
• 2005 Sales:1269 Crores
• Employees: 1870
• Major Industry: PERSONAL CARE & HEALTH
CARE,FOODS
• Leading Brands: Dabur Amla, Dabur
Chyawanaprash, Vatika, Hajmola, Lal Dant
Manjan, Pudin Hara and the Real range of fruit
juices.
• Positioning –Unique
• COMPETITORS: COLGATE-PALMOLIVE,GILLETTE,HLL,
MARICO,POND’S,P & G, RECKITT BENCKISER

5. NEW INITIATIVES AND FUTURE
PLANS
• Re-structure sales and distribution
- savings of 10-12 crores annually
 Pharma separated from FMCG
 Separate CHD
 Exports- thrust area
 War chest of Rs. 200 crores for
acquisitions
 Acquisition of Balsara

6. PROMISEing Acquisition
• Dabur India acquired the entire promoter
stake in three Balsara companies – 99.4%
in Balsara Hygiene Products; 100% in
Balsara Home Products and 97.9% in
Besta Cosmetics.
• It was an all cash deal of Rs1.43bn
(US$33mn).
• The companies would originally operate
as subsidiaries of Dabur India.

7. • Rationale for deal
 Strengthens Dabur’s position in oral
care
 Adds a new avenues of growth :
Household care
 Enables Dabur to expand regional
presence
 Economies of scale from combined
business

8. FINANCIALS
FY 04-05 FY03-04 % CHANGES
SALES
TURNOVER
1268.7 1147.9 10.52
TOTAL INCOME 1280 1159 10.46
TOTAL
EXPENDITURE
1093.8 1022.9 06.93
OPERATING
PROFIT
186.4 136 36.99
GROSS PROFIT 182.1 129.1 40.98
DEPRECIATION 17.1 15.75 08.57
TAX 17.00 12.24 38.99
PAT 148 101.2 46.27

9. Thank You

10. Thank You